Published on 21 Feb 2024 on Bloomberg via Yahoo Finance
(Bloomberg) -- Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., according to people with knowledge of the matter.
Most Read from Bloomberg
Nvidia Surges After Company Proclaims AI Has Hit 'Tipping Point'Biden Touts $1.2 Billion in Student Loan Relief With Eye to 2024Tech Up in Late Hours on Nvidia’s Bullish Outlook: Markets WrapChina Tightens Grip on Stocks With Net Sale Ban at Open, CloseYour 401(k) Will Be Gone Within a Decade